Imaging outcomes for trials of remyelination in multiple sclerosis.
Ontology highlight
ABSTRACT: Trials of potential neuroreparative agents are becoming more important in the spectrum of multiple sclerosis research. Appropriate imaging outcomes are required that are feasible from a time and practicality point of view, as well as being sensitive and specific to myelin, while also being reproducible and clinically meaningful. Conventional MRI sequences have limited specificity for myelination. We evaluate the imaging modalities which are potentially more specific to myelin content in vivo, such as magnetisation transfer ratio (MTR), restricted proton fraction f (from quantitative magnetisation transfer measurements), myelin water fraction and diffusion tensor imaging (DTI) metrics, in addition to positron emission tomography (PET) imaging. Although most imaging applications to date have
SUBMITTER: Mallik S
PROVIDER: S-EPMC4335693 | biostudies-literature | 2014 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA